BioHealth News Archive
Save the Date! 2020 BioHealth Capital Region Forum (2)
This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, Virginia Bio, Children’s National Health System, Johns Hopkins…
Read More
Save the Date! 2020 BioHealth Capital Region Forum
This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, Virginia Bio, Children’s National Health System, Johns Hopkins…
Read More
First Published Clinical Trial Using Live Biotherapeutic Candidate In COVID-19 Patients Suggests Role In Improving Outcomes – MarketWatch
ROCKVILLE, Md., July 13, 2020 /PRNewswire via COMTEX/ -- ROCKVILLE, Md., July 13, 2020 /PRNewswire/ -- ExeGi Pharma LLC, a U.S.-based company focused on…
Read More
Montgomery County’s unique biohealth and life science organizations are working to test, beat and cure COVID-19 | WTOP
While COVID-19 has thrown the world into an uproar, there’s been a slim silver lining for Maryland. Thanks to a robust group of biohealth…
Read More
U.S. government awards Novavax $1.6 billion for coronavirus vaccine | News | 1450 99.7 WHTC
CHICAGO (Reuters) - The U.S. government has awarded Novavax Inc $1.6 billion to cover testing and manufacturing of a potential vaccine for the novel…
Read More
Alexandria Real Estate Equities, Inc. Announces Pricing Of Upsized Public Offering Of 6,000,000 Shares Of Common Stock
PASADENA, Calif., July 6, 2020 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the pricing of its upsized public…
Read More
REGENXBIO Provides Update on Progress of Clinical Programs for Rare Genetic Neurodegenerative Diseases
ROCKVILLE, Md., July 8, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of…
Read More
Commentary: Washington wants to forfeit our best weapon against coronavirus | Columnists | elkodaily.com
Rep. Jan Schakowsky (D-IL) and several senior House lawmakers recently announced a plan to impose price controls and seize patents on any COVID-19 vaccines…
Read More
Meet the Researcher Leading NIH’s COVID-19 Vaccine Development Efforts – Government Executive
Asafe, effective vaccine is the ultimate tool needed to end the coronavirus disease 2019 (COVID-19) pandemic. Biomedical researchers are making progress every day towards…
Read More
Johns Hopkins calls new federal rules for international students ‘disturbing’ and ‘draconian’ – Baltimore Business Journal
Hopkins has the highest percentage of international students of any Maryland college. {iframe}https://www.bizjournals.com/baltimore/news/2020/07/08/hopkins-opposes-federal-rule-international-student.html{/iframe}
Read More
Where Providence Ventures is investing millions — 17 portfolio companies including Protenus
Providence Ventures was founded in 2014 and manages $300 million of venture capital in two funds. The company is affiliated with Providence, a 51-hospital…
Read MoreJohns Hopkins statement re: SEVP lawsuit filed today
BALTIMORE, July 10, 2020 /PRNewswire/ -- Johns Hopkins University filed suit in federal court Friday in an effort to stop a Trump administration rule…
Read More
Johns Hopkins’ Covid-19 map: Meet the team behind the leading resource – CNN
(CNN) - If the year 2020 is good for anything, it's the lesson that during a crisis, anyone who builds a better mousetrap will…
Read More
Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent’s COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding | Emergent BioSolutions Inc.
NEW YORK and GAITHERSBURG, Md. and NEW ORLEANS and LAFAYETTE, La., July 08, 2020 (GLOBE NEWSWIRE) -- The Mount Sinai Health System, Emergent BioSolutions…
Read More
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
VIENNA, AUSTRIA and GAITHERSBURG, MD, July 8, 2020 APEIRON Biologics AG (“APEIRON”), a private biotechnology company specializing in the discovery, development and commercialization of…
Read More